Bibliographie (2530)
![[Press release – results not published yet] International trials of blood thinners in critically ill COVID-19 patients pause due to futility](/media/k2/items/cache/b9ad772005653afce4d4bd46c2efe842_L.jpg)
[Press release – results not published yet] International trials of blood thinners in critically ill COVID-19 patients pause due to futility
mardi, 12 janvier 2021 13:54 Écrit par Zouhair SouissiInternational trials of blood thinners in critically ill COVID-19 patients pause due to futility – NIH News Releases Commentary on Twitter The 3 largest RCTs of therapeutic #anticoagulation for #COVID19 pts in the ICU have ALL been stopped early for futility. (@remap_cap @ATTACC_COVID & #ACTIV4) Nothing published yet, but given the large n of […]
The post [Press release – results not published yet] International trials of blood thinners in critically ill COVID-19 patients pause due to futility appeared first on Links Medicus.
Long Covid: 6-month consequences of COVID-19 in patients discharged from hospital
mardi, 12 janvier 2021 13:54 Écrit par Zouhair Souissi6-month consequences of COVID-19 in patients discharged from hospital: a cohort study – The Lancet Commentaries: Most patients hospitalized for Covid-19 still have symptoms six months later, China study finds AND Long-term follow-up of recovered patients with COVID-19 – The Lancet Commentary on Twitter Largest #LongCovid cohort @TheLancet just published:6 months post-hospital, —76% still […]
The post Long Covid: 6-month consequences of COVID-19 in patients discharged from hospital appeared first on Links Medicus.
Peter Doshi: Pfizer and Moderna’s “95% effective” vaccines—we need more details and the raw data
mardi, 12 janvier 2021 13:54 Écrit par Zouhair SouissiPeter Doshi: Pfizer and Moderna’s “95% effective” vaccines—we need more details and the raw data – The BMJ Opinion
The post Peter Doshi: Pfizer and Moderna’s “95% effective” vaccines—we need more details and the raw data appeared first on Links Medicus.
Sinovac vaccine 78% effective in Brazil trial, experts call for more details
mardi, 12 janvier 2021 13:54 Écrit par Zouhair SouissiSinovac vaccine 78% effective in Brazil trial, experts call for more details – Reuters See also: Brazil announces ‘fantastic’ results for Chinese-made COVID-19 vaccine, but details remain sketchy – Science
The post Sinovac vaccine 78% effective in Brazil trial, experts call for more details appeared first on Links Medicus.
Debate: Should we delay second vaccine doses to give one dose of the Covid-19 vaccine to more people?
mardi, 12 janvier 2021 13:54 Écrit par Zouhair SouissiEditorial: U.S. COVID-19 Vaccination Challenges Go Beyond Supply – Annals of Internal Medicine Speed Versus Efficacy: Quantifying Potential Tradeoffs in COVID-19 Vaccine Deployment – Annals of Internal Medicine A Public Health COVID-19 Vaccination Strategy to Maximize the Health Gains for Every Single Vaccine Dose – Annals of Internal Medicine Alternative Dose Allocation Strategies to Increase […]
The post Debate: Should we delay second vaccine doses to give one dose of the Covid-19 vaccine to more people? appeared first on Links Medicus.
Moderna COVID-19 vaccine phase III trial results published; it is 94.1% efficacious in preventing symptomatic COVID-19
mardi, 12 janvier 2021 13:54 Écrit par Zouhair SouissiEfficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine – New England Journal of Medicine Commentaries: Peer-reviewed report on Moderna COVID-19 vaccine publishes – NIH News Releases AND Peer-reviewed data show high protection for leading COVID vaccines – CIDRAP AND The Moderna Vaccine’s Antibodies May Not Last As Long As We Hoped – Forbes Commentary […]
The post Moderna COVID-19 vaccine phase III trial results published; it is 94.1% efficacious in preventing symptomatic COVID-19 appeared first on Links Medicus.
Randomized trial: Neutralizing monoclonal antibody not efficacious among hospitalized patients with covid-19
mardi, 12 janvier 2021 13:54 Écrit par Zouhair SouissiA Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19 – New England Journal of Medicine Commentaries: Covid-19: Trial of LY-CoV555 Stopped for Futility – Physician’s Weekly AND Results of NIH-sponsored ACTIV-3 trial published – NIH News Releases AND Bamlanivimab Flops in Hospitalized COVID-19 Patients – MedPage Today (free registration required)
The post Randomized trial: Neutralizing monoclonal antibody not efficacious among hospitalized patients with covid-19 appeared first on Links Medicus.
New SARS-CoV-2 variants: increased transmissibility likely to cause more deaths and possibly a new wave of the disease
mardi, 12 janvier 2021 13:54 Écrit par Zouhair SouissiSARS-CoV-2 Variants – World Health Organization Why epidemiologists are so worried about the new Covid-19 variants, in 2 charts – Vox We lost to SARS-CoV-2 in 2020. We can defeat B-117 in 2021 – STAT Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: insights from linking epidemiological and genetic data – Imperial College of London AND […]
The post New SARS-CoV-2 variants: increased transmissibility likely to cause more deaths and possibly a new wave of the disease appeared first on Links Medicus.
CDC Study: Among young, healthy athletes exposed to Covid-19, the probability of receiving positive test results after day 10 of quarantine is low (less than 5%)
mardi, 12 janvier 2021 13:54 Écrit par Zouhair SouissiTime from Start of Quarantine to SARS-CoV-2 Positive Test Among Quarantined College and University Athletes — 17 States, June–October 2020 – CDC Morbidity and Mortality Weekly Report Commentary on Twitter A new @CDCMMWR looking at college athletes exposed to #COVID19 supports giving health departments options to potentially shorten quarantine periods to increase adherence. Learn […]
The post CDC Study: Among young, healthy athletes exposed to Covid-19, the probability of receiving positive test results after day 10 of quarantine is low (less than 5%) appeared first on Links Medicus.
Randomized trial: Renin–angiotensin system inhibitors can be safely continued in patients admitted to hospital with COVID-19
mardi, 12 janvier 2021 13:54 Écrit par Zouhair SouissiContinuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial – The Lancet Respiratory Medicine Commentary: Commonly used blood pressure medications safe for COVID-19 patients, study finds – University of Pennsylvania School of Medicine NEW Research—renin–angiotensin system inhibitors can be safely continued in patients admitted […]
The post Randomized trial: Renin–angiotensin system inhibitors can be safely continued in patients admitted to hospital with COVID-19 appeared first on Links Medicus.
![[Preprint] Randomized trial: Arthritis drugs improve survival in critically ill patients with Covid-19](/media/k2/items/cache/513d7a0ab11e38f7bd117d760146fed3_XS.jpg)
